持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/09/15 | 3,585 | 3,610 | 3,560 | 3,565 | -75 | -2.1% | 75,000 |
| 2021/09/14 | 3,585 | 3,655 | 3,585 | 3,640 | +30 | +0.8% | 75,100 |
| 2021/09/13 | 3,595 | 3,615 | 3,560 | 3,610 | -10 | -0.3% | 63,400 |
| 2021/09/10 | 3,585 | 3,620 | 3,550 | 3,620 | -15 | -0.4% | 114,800 |
| 2021/09/09 | 3,670 | 3,685 | 3,615 | 3,635 | -60 | -1.6% | 49,100 |
| 2021/09/08 | 3,680 | 3,700 | 3,665 | 3,695 | +35 | +1% | 38,400 |
| 2021/09/07 | 3,700 | 3,700 | 3,645 | 3,660 | +5 | +0.1% | 65,300 |
| 2021/09/06 | 3,640 | 3,670 | 3,610 | 3,655 | +15 | +0.4% | 60,900 |
| 2021/09/03 | 3,600 | 3,685 | 3,585 | 3,640 | +30 | +0.8% | 59,000 |
| 2021/09/02 | 3,635 | 3,635 | 3,585 | 3,610 | -60 | -1.6% | 42,000 |
| 2021/09/01 | 3,660 | 3,670 | 3,635 | 3,670 | +5 | +0.1% | 27,800 |
| 2021/08/31 | 3,600 | 3,695 | 3,590 | 3,665 | +75 | +2.1% | 56,800 |
| 2021/08/30 | 3,590 | 3,610 | 3,565 | 3,590 | +15 | +0.4% | 20,100 |
| 2021/08/27 | 3,555 | 3,595 | 3,550 | 3,575 | +15 | +0.4% | 39,600 |
| 2021/08/26 | 3,610 | 3,610 | 3,560 | 3,560 | -45 | -1.2% | 34,000 |
| 2021/08/25 | 3,620 | 3,630 | 3,580 | 3,605 | -25 | -0.7% | 41,000 |
| 2021/08/24 | 3,595 | 3,630 | 3,580 | 3,630 | -5 | -0.1% | 54,700 |
| 2021/08/23 | 3,565 | 3,650 | 3,560 | 3,635 | +90 | +2.5% | 70,400 |
| 2021/08/20 | 3,570 | 3,590 | 3,525 | 3,545 | ±0 | ±0% | 40,400 |
| 2021/08/19 | 3,520 | 3,560 | 3,520 | 3,545 | -25 | -0.7% | 36,900 |
| 2021/08/18 | 3,560 | 3,590 | 3,550 | 3,570 | +40 | +1.1% | 22,100 |
| 2021/08/17 | 3,510 | 3,565 | 3,500 | 3,530 | +40 | +1.1% | 38,600 |
| 2021/08/16 | 3,540 | 3,540 | 3,460 | 3,490 | -65 | -1.8% | 40,100 |
| 2021/08/13 | 3,510 | 3,570 | 3,510 | 3,555 | +40 | +1.1% | 21,300 |
| 2021/08/12 | 3,605 | 3,605 | 3,510 | 3,515 | -70 | -2% | 28,300 |
| 2021/08/11 | 3,575 | 3,610 | 3,565 | 3,585 | +55 | +1.6% | 35,400 |
| 2021/08/10 | 3,495 | 3,565 | 3,495 | 3,530 | +35 | +1% | 46,100 |
| 2021/08/06 | 3,495 | 3,540 | 3,480 | 3,495 | ±0 | ±0% | 25,200 |
| 2021/08/05 | 3,475 | 3,520 | 3,470 | 3,495 | +20 | +0.6% | 30,700 |
| 2021/08/04 | 3,500 | 3,535 | 3,475 | 3,475 | -25 | -0.7% | 45,500 |
| 2021/08/03 | 3,585 | 3,585 | 3,495 | 3,500 | -70 | -2% | 42,800 |
| 2021/08/02 | 3,585 | 3,610 | 3,560 | 3,570 | -15 | -0.4% | 64,300 |
| 2021/07/30 | 3,640 | 3,655 | 3,580 | 3,585 | -55 | -1.5% | 55,400 |
| 2021/07/29 | 3,665 | 3,675 | 3,640 | 3,640 | ±0 | ±0% | 24,900 |
| 2021/07/28 | 3,655 | 3,695 | 3,640 | 3,640 | -30 | -0.8% | 25,400 |
| 2021/07/27 | 3,680 | 3,690 | 3,645 | 3,670 | ±0 | ±0% | 27,800 |
| 2021/07/26 | 3,665 | 3,685 | 3,635 | 3,670 | +45 | +1.2% | 38,000 |
| 2021/07/21 | 3,640 | 3,655 | 3,605 | 3,625 | +35 | +1% | 28,500 |
| 2021/07/20 | 3,595 | 3,615 | 3,565 | 3,590 | -45 | -1.2% | 31,100 |
| 2021/07/19 | 3,600 | 3,640 | 3,590 | 3,635 | -10 | -0.3% | 39,100 |
| 2021/07/16 | 3,650 | 3,695 | 3,645 | 3,645 | -35 | -1% | 25,100 |
| 2021/07/15 | 3,775 | 3,775 | 3,680 | 3,680 | -50 | -1.3% | 45,200 |
| 2021/07/14 | 3,725 | 3,775 | 3,715 | 3,730 | +10 | +0.3% | 32,400 |
| 2021/07/13 | 3,690 | 3,730 | 3,680 | 3,720 | -5 | -0.1% | 35,500 |
| 2021/07/12 | 3,700 | 3,735 | 3,660 | 3,725 | +135 | +3.8% | 46,200 |
| 2021/07/09 | 3,575 | 3,600 | 3,525 | 3,590 | -55 | -1.5% | 69,400 |
| 2021/07/08 | 3,635 | 3,695 | 3,615 | 3,645 | -15 | -0.4% | 58,600 |
| 2021/07/07 | 3,585 | 3,660 | 3,565 | 3,660 | +10 | +0.3% | 68,700 |
| 2021/07/06 | 3,660 | 3,660 | 3,615 | 3,650 | +30 | +0.8% | 27,800 |
| 2021/07/05 | 3,635 | 3,655 | 3,610 | 3,620 | -15 | -0.4% | 19,900 |
901～
950
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
